Tgf-β3-induced palatal fusion is mediated by Alk-5/Smad pathway
- 19 November 2003
- journal article
- Published by Elsevier in Developmental Biology
- Vol. 266 (1) , 96-108
- https://doi.org/10.1016/j.ydbio.2003.10.007
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- TGF‐β3–dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusionDevelopmental Dynamics, 2003
- Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced ResponsesJournal of Biological Chemistry, 2003
- PI‐3 kinase activity is required for epithelial‐mesenchymal transformation during palate fusionDevelopmental Dynamics, 2002
- Smad3 allostery links TGF-β receptor kinase activation to transcriptional controlGenes & Development, 2002
- From mono- to oligo-Smads: The heart of the matter in TGF-β signal transduction: Figure 1.Genes & Development, 2002
- SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7Molecular Pharmacology, 2002
- Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)Journal of Medicinal Chemistry, 2002
- Integrin β1 Signaling Is Necessary for Transforming Growth Factor-β Activation of p38MAPK and Epithelial PlasticityJournal of Biological Chemistry, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997